Elbasvir (MK-8742)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Elbasvir (MK-8742), covering 2016-03-04 to 2016-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With or Without Ribavirin for Participants With Hepatitis C Genotype 1, 4, or 6 Infections Who Have Failed Prior Treatment With Pegylated Interferon + Ribavirin (MK-5172-068) [Phase 3]